Oluyomi M Okunola-Bakare

Title: Oluyomi M Okunola-Bakare: Innovator in Neuropharmacology

Introduction

Oluyomi M Okunola-Bakare is a distinguished inventor based in Beltsville, MD (US). He has made significant contributions to the field of neuropharmacology, particularly through his innovative work on monoamine transporters. With a total of 4 patents, his research focuses on developing compounds that can effectively influence neurotransmitter reuptake.

Latest Patents

His latest patents include "Potent and selective inhibitors of monoamine transporters; method of making; and use thereof." This patent discloses bisarylmethylthioacetamides and bisarylmethylthioethylamines that serve as inhibitors of monoamine transporters. The compounds are recognized for their potency and selectivity in inhibiting dopamine (DA), serotonin (5-HT), and norepinephrine (NE) reuptake via their respective transporters, DAT, SERT, and NET. Additionally, the patent outlines methods for eliciting wake-promoting effects and treating various neuropsychiatric disorders, including substance use disorders, attention deficit (hyperactivity) disorder, and depressive disorders.

Career Highlights

Throughout his career, Oluyomi has worked with notable organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to contribute to significant advancements in medical research and drug development.

Collaborations

He has collaborated with esteemed colleagues such as Amy Hauck Newman and Jianjing Cao, further enhancing the impact of his research in the scientific community.

Conclusion

Oluyomi M Okunola-Bakare's innovative work in the field of neuropharmacology exemplifies the importance of research in developing effective treatments for neuropsychiatric disorders. His contributions continue to influence the landscape of medical science and drug development.